• DOI:10.1007/S10227-004-0115-7
Corpus ID: 23838714

A Review of the Use of Infliximab to Manage Cutaneous Dermatoses

@article{Gupta2004ARO,
  title={A Review of the Use of Infliximab to Manage Cutaneous Dermatoses},
  author={A. Gupta and A. R. Skinner},
  journal={Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology},
  year={2004},
  volume={8},
  pages={77-89}
}

A. Gupta, A. R. Skinner

Published 2004

Medicine

Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology

BackgroundInfliximab is a chimeric monoclonal antibody that binds specifically to human tumor necrosis factor-alpha (TNF-α), decreasing the effect of the cytokine in inflammatory diseases.ObjectiveThe aim of this study was to review the efficacy and safety of infliximab in the treatment of dermatological diseases.MethodsA MEDLINE search (1966–January 2003), using the keyword “infliximab” was performed to find relevant articles pertaining to the use of infliximab in dermatology.ResultsInfliximab… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed